The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment. Under the leadership of our Interim Chief Executive, Professor Paul Workman FMedSci, the ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top four cancer centres globally. The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer.
The Molecular and Population Genetics team at ICR has a strong track record of successful research in discovering new cancer genes and in translating the findings for clinical benefit.
We are seeking an enthusiastic, self-motivated individual to conduct bioinformatic research within the scope of the group’s on-going multiple myeloma projects. This will involve developing frameworks to tackle new computational and statistical challenges arising from next generation sequencing, and analysis of existing datasets, often innovating new methods to further explore the data beyond what classical protocols allow.
The successful applicant should have a PhD in bioinformatics or related subject. The post-holder will work closely with bioinformaticians, statisticians and molecular biologists within the team as well as conducting independent research.
Informal enquiries are welcome and can be made to Professor Richard Houlston(Richard.houlston@icr.ac.uk). PLEASE NOTE– this address is for enquiries only and applications must be submitted via the apply button below http://www.statsjobs.com/jobs/bioinformatician-institute-cancer-research/
No hay comentarios:
Publicar un comentario